Literature DB >> 31968243

Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival.

Caley J Burrus1, Spencer U McKinstry2, Namsoo Kim3, M Ilcim Ozlu2, Aditya V Santoki2, Francia Y Fang2, Annie Ma2, Yonca B Karadeniz2, Atesh K Worthington2, Ioannis Dragatsis4, Scott Zeitlin5, Henry H Yin6, Cagla Eroglu7.   

Abstract

Huntington's disease (HD) is caused by an autosomal dominant polyglutamine expansion mutation of Huntingtin (HTT). HD patients suffer from progressive motor, cognitive, and psychiatric impairments, along with significant degeneration of the striatal projection neurons (SPNs) of the striatum. HD is widely accepted to be caused by a toxic gain-of-function of mutant HTT. However, whether loss of HTT function, because of dominant-negative effects of the mutant protein, plays a role in HD and whether HTT is required for SPN health and function are not known. Here, we delete Htt from specific subpopulations of SPNs using the Cre-Lox system and find that SPNs require HTT for motor regulation, synaptic development, cell health, and survival during aging. Our results suggest that loss of HTT function in SPNs could play a critical role in HD pathogenesis.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Huntington's Disease; basal ganglia; neuronal survival; striatum; synaptic connectivity

Year:  2020        PMID: 31968243      PMCID: PMC7025500          DOI: 10.1016/j.celrep.2019.12.069

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  72 in total

1.  Wild-type huntingtin protects neurons from excitotoxicity.

Authors:  Blair R Leavitt; Jeremy M van Raamsdonk; Jacqueline Shehadeh; Herman Fernandes; Zoe Murphy; Rona K Graham; Cheryl L Wellington; Lynn A Raymond; Michael R Hayden
Journal:  J Neurochem       Date:  2006-01-17       Impact factor: 5.372

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

3.  A morphologically conserved nonapoptotic program promotes linker cell death in Caenorhabditis elegans.

Authors:  Mary C Abraham; Yun Lu; Shai Shaham
Journal:  Dev Cell       Date:  2007-01       Impact factor: 12.270

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes.

Authors:  Jianhua Zhang; Lu Zhang; Hongyuan Jiao; Qi Zhang; Dongsheng Zhang; Danwen Lou; Jonathan L Katz; Ming Xu
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

6.  Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development.

Authors:  Yiai Tong; Thomas J Ha; Li Liu; Andrew Nishimoto; Anton Reiner; Dan Goldowitz
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

7.  GENSAT BAC cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits.

Authors:  Charles R Gerfen; Ronald Paletzki; Nathaniel Heintz
Journal:  Neuron       Date:  2013-12-18       Impact factor: 17.173

8.  Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.

Authors:  Zhaoyang Li; Cen Wang; Ziying Wang; Chenggang Zhu; Jie Li; Tian Sha; Lixiang Ma; Chao Gao; Yi Yang; Yimin Sun; Jian Wang; Xiaoli Sun; Chenqi Lu; Marian Difiglia; Yanai Mei; Chen Ding; Shouqing Luo; Yongjun Dang; Yu Ding; Yiyan Fei; Boxun Lu
Journal:  Nature       Date:  2019-10-30       Impact factor: 49.962

Review 9.  Normal huntingtin function: an alternative approach to Huntington's disease.

Authors:  Elena Cattaneo; Chiara Zuccato; Marzia Tartari
Journal:  Nat Rev Neurosci       Date:  2005-12       Impact factor: 34.870

10.  Astrocytic neuroligins control astrocyte morphogenesis and synaptogenesis.

Authors:  Jeff A Stogsdill; Juan Ramirez; Di Liu; Yong Ho Kim; Katherine T Baldwin; Eray Enustun; Tiffany Ejikeme; Ru-Rong Ji; Cagla Eroglu
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

View more
  13 in total

1.  Allele-Specific Knockdown of Mutant Huntingtin Protein via Editing at Coding Region Single Nucleotide Polymorphism Heterozygosities.

Authors:  Sarah R Oikemus; Edith L Pfister; Ellen Sapp; Kathryn O Chase; Lori A Kennington; Edward Hudgens; Rachael Miller; Lihua Julie Zhu; Akanksh Chaudhary; Eric O Mick; Miguel Sena-Esteves; Scot A Wolfe; Marian DiFiglia; Neil Aronin; Michael H Brodsky
Journal:  Hum Gene Ther       Date:  2022-01       Impact factor: 5.695

2.  Characterization of a Knock-In Mouse Model with a Huntingtin Exon 1 Deletion.

Authors:  Elise M Braatz; Emily A André; Jeh-Ping Liu; Scott O Zeitlin
Journal:  J Huntingtons Dis       Date:  2021

3.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

4.  Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington's disease mice.

Authors:  Rafael Alcalá-Vida; Jonathan Seguin; Caroline Lotz; Anne M Molitor; Ibai Irastorza-Azcarate; Ali Awada; Nezih Karasu; Aurélie Bombardier; Brigitte Cosquer; Jose Luis Gomez Skarmeta; Jean-Christophe Cassel; Anne-Laurence Boutillier; Thomas Sexton; Karine Merienne
Journal:  Nat Commun       Date:  2021-01-13       Impact factor: 14.919

5.  Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease.

Authors:  Mehdi Eshraghi; Pabalu P Karunadharma; Juliana Blin; Neelam Shahani; Emiliano P Ricci; Audrey Michel; Nicolai T Urban; Nicole Galli; Manish Sharma; Uri Nimrod Ramírez-Jarquín; Katie Florescu; Jennifer Hernandez; Srinivasa Subramaniam
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

6.  An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion.

Authors:  Caroline Gubser Keller; Youngah Shin; Alex Mas Monteys; Nicole Renaud; Martin Beibel; Natalia Teider; Thomas Peters; Thomas Faller; Sophie St-Cyr; Judith Knehr; Guglielmo Roma; Alejandro Reyes; Marc Hild; Dmitriy Lukashev; Diethilde Theil; Natalie Dales; Jang-Ho Cha; Beth Borowsky; Ricardo Dolmetsch; Beverly L Davidson; Rajeev Sivasankaran
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

7.  The long and the short of Huntington's disease: how the sphingolipid profile is shifted in the caudate of advanced clinical cases.

Authors:  Gabrielle R Phillips; Jennifer T Saville; Sarah E Hancock; Simon H J Brown; Andrew M Jenner; Catriona McLean; Maria Fuller; Kelly A Newell; Todd W Mitchell
Journal:  Brain Commun       Date:  2021-12-23

8.  Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model.

Authors:  Rachel Y Cheong; Barbara Baldo; Muhammad U Sajjad; Deniz Kirik; Åsa Petersén
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-12       Impact factor: 8.090

Review 9.  Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin.

Authors:  Annarita Fiorillo; Veronica Morea; Gianni Colotti; Andrea Ilari
Journal:  J Pers Med       Date:  2021-12-06

10.  A Progressive Loss of phosphoSer138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington's Disease: Possible Sex-Dependent Signaling.

Authors:  Akanksha Baharani; Zelan Wei; William J Roesler; Darrell D Mousseau
Journal:  Cell Mol Neurobiol       Date:  2020-10-27       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.